raloxifene hydrochloride has been researched along with Protein Aggregation, Pathological in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, X; Chen, D; Feng, Y; Liu, Z; Qin, W; Shao, W; Su, H; Wang, Y; Zhou, B | 1 |
1 other study(ies) available for raloxifene hydrochloride and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Raloxifene alleviates amyloid-β-induced cytotoxicity in HT22 neuronal cells via inhibiting oligomeric and fibrillar species formation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line; Cell Survival; Gene Expression; Hydrophobic and Hydrophilic Interactions; Mice; Microglia; Neurons; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Protein Domains; Raloxifene Hydrochloride; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2019 |